APH vs CAI · P/E 40, rev $23.09B vs rev $216.8M
Amphenol Corporation (APH) versus Caris Life Sciences, Inc. Common Stock (CAI) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
APH currently screens at market cap $170.77B and trailing P/E 39.9. CAI currently screens at market cap $5.22B.
Not investment advice. Open the APH and CAI stock pages for the full models.
Not investment advice.